3-(6-butyl-5-oxo-9H-[1,2,4]triazolo[3,4-f]purin-8-yl)-N,N-bis(2-hydroxyethyl)-4-propoxybenzenesulfonamide
C23H31N7O6S — CID 135788436
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-(6-butyl-5-oxo-9H-[1,2,4]triazolo[3,4-f]purin-8-yl)-N,N-bis(2-hydroxyethyl)-4-propoxybenzenesulfonamide
3-(6-butyl-5-oxo-9H-[1,2,4]triazolo[3,4-f]purin-8-yl)-N,N-bis(2-hydroxyethyl)-4-propoxybenzenesulfonamide (PubChem CID 135788436) has the molecular formula C23H31N7O6S and a molecular weight of 533.61 g/mol. Its IUPAC name is 3-(6-butyl-5-oxo-9H-[1,2,4]triazolo[3,4-f]purin-8-yl)-N,N-bis(2-hydroxyethyl)-4-propoxybenzenesulfonamide.
Molecular Properties
| Compound Name | 3-(6-butyl-5-oxo-9H-[1,2,4]triazolo[3,4-f]purin-8-yl)-N,N-bis(2-hydroxyethyl)-4-propoxybenzenesulfonamide |
|---|---|
| PubChem CID | 135788436 |
| Molecular Formula | C23H31N7O6S |
| Molecular Weight | 533.61 g/mol |
| Exact Mass | 533.21 |
| IUPAC Name | 3-(6-butyl-5-oxo-9H-[1,2,4]triazolo[3,4-f]purin-8-yl)-N,N-bis(2-hydroxyethyl)-4-propoxybenzenesulfonamide |
| SMILES | CCCCn1c(=O)n2cnnc2c2[nH]c(-c3cc(S(=O)(=O)N(CCO)CCO)ccc3OCCC)nc21 |
| InChI | InChI=1S/C23H31N7O6S/c1-3-5-8-29-21-19(22-27-24-15-30(22)23(29)33)25-20(26-21)17-14-16(6-7-18(17)36-13-4-2)37(34,35)28(9-11-31)10-12-32/h6-7,14-15,31-32H,3-5,8-13H2,1-2H3,(H,25,26) |
| InChIKey | KPWZUMBFUSRJNC-UHFFFAOYSA-N |
| XLogP | 1.00 |
| TPSA | 167.94 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 11 |
| Rotatable Bonds | 13 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 533.61 |
| LogP ≤ 5 | 1.00 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 11 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 135788436 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.